利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

31 条记录 (耗时 0.02 秒)

    Preparation for administration to animals and feeding method thereof
    1.
    发明授权
    Preparation for administration to animals and feeding method thereof 失效
    给予动物的制剂及其饲养方法

    公开(公告)号：US06299912B1

    公开(公告)日：2001-10-09

    申请号：US09556460

    申请日：2000-04-24

    申请人： Shinobu Ito ,  Kuniaki Shimbo ,  Eiji Ogata

    发明人： Shinobu Ito ,  Kuniaki Shimbo ,  Eiji Ogata

    IPC分类号： A23K100

    CPC分类号： A23K50/80 ,  A23K20/174 ,  A23K20/189 ,  A23K50/00 ,  A23K50/10 ,  A23K50/40 ,  A23K50/75 ,  Y10S426/805 ,  Y10S426/807

    摘要： A preparation for administration to animals, comprising a sparingly soluble L-ascorbic acid-2-phosphoric ester salt having a solubility in water of 10 wt % or less, the solubility being a value obtained by placing 100 g of purified water in a 200 ml-volume beaker, stirring the water while keeping the temperature at 20° C., adding 0.1 g of the L-ascorbic acid-2-phosphoric ester salt every 5 minutes by taking care not to cause gelation, and 30 minutes after the addition of L-ascorbic acid-2-phosphoric ester salt when the undissolved L-ascorbic acid-2-phosphoric ester salt is observed visually in the aqueous solution, determining the amount in weight percentage of L-ascorbic acid-2-phosphoric ester salt added based on water, and a method for feeding animals, using the preparation.

    摘要翻译： 一种用于给予动物的制剂，其包含在水中的溶解度为10重量％以下的微溶L-抗坏血酸-2-磷酸酯盐，其溶解度为将100g纯化水放入200ml 在保持温度为20℃的同时搅拌水，每5分钟加入0.1g L-抗坏血酸-2-磷酸酯盐，注意不引起凝胶化，加入后30分钟 在水溶液中观察未溶解的L-抗坏血酸-2-磷酸酯盐时，测定L-抗坏血酸-2-磷酸酯盐的重量百分比量 在水上，以及饲养动物的方法。

    Composition for enhancing immunological effects
    2.
    发明授权
    Composition for enhancing immunological effects 失效
    用于增强免疫学效果的组合物

    公开(公告)号：US06635253B2

    公开(公告)日：2003-10-21

    申请号：US09794161

    申请日：2001-02-28

    申请人： Shinobu Ito ,  Eiji Ogata

    发明人： Shinobu Ito ,  Eiji Ogata

    IPC分类号： A61K3938

    CPC分类号： A61K47/24 ,  A61K9/0019 ,  A61K31/375 ,  A61K31/665 ,  A61K39/39 ,  A61K45/06 ,  A61K47/22 ,  A61K2039/55511

    摘要： An object of the present invention is to provide a composition for enhancing the immunological effects of a vaccine for viruses, bacteria and/or infectious disease pathogens, containing a stable activity-type provitamin; a method for enhancing the immunological effects of a vaccine for viruses, bacteria and/or infectious disease pathogens by administering the composition; and a method of employing the composition. A composition for enhancing the immunological effects of a vaccine for viruses, bacteria and/or infectious disease pathogens, contains L-ascorbic acid-2-phosphate and/or &agr;-tocopheryl phosphate as a stable activity antioxidant provitamin.

    摘要翻译： 本发明的目的是提供一种用于增强含有稳定的活性型前病毒的病毒，细菌和/或感染性疾病病原体的疫苗的免疫效果的组合物; 通过施用组合物来增强疫苗对病毒，细菌和/或感染性疾病病原体的免疫效果的方法; 和采用该组合物的方法。 用于增强疫苗对病毒，细菌和/或感染性疾病病原体的免疫效果的组合物含有L-抗坏血酸-2-磷酸和/或α-生育酚磷酸酯作为稳定活性的抗氧化剂前维生素。

    Agent for preventing and treating skin diseases
    3.
    发明授权
    Agent for preventing and treating skin diseases 失效
    预防和治疗皮肤病的药剂

    公开(公告)号：US06437002B1

    公开(公告)日：2002-08-20

    申请号：US09418317

    申请日：1999-10-14

    申请人： Shinobu Ito ,  Eiji Ogata ,  Hiroshi Ikeno

    发明人： Shinobu Ito ,  Eiji Ogata ,  Hiroshi Ikeno

    IPC分类号： A61K3100

    CPC分类号： C07F9/65515 ,  A61K8/11 ,  A61K8/14 ,  A61K8/676 ,  A61K9/127 ,  A61K31/7048 ,  A61K2800/412 ,  A61K2800/522 ,  A61Q19/00 ,  A61Q19/02 ,  A61Q19/10 ,  C07D307/62

    摘要： The present invention relates to an agent for preventing and treating skin diseases comprising as an active ingredient an ascorbic acid derivative which is a compound represented by the following formula (1) or a salt thereof and which per se exhibits no anti-oxidation activity but is capable of transforming in vivo into a compound having an anti-oxidation activity; wherein R1 represents a group capable of bonding to the carbon at the 2-position of the ascorbic acid skeleton through an ether or ester bond and transformable in vivo into a hydroxyl group, and R2 to R4 may be the same or different and each represents a hydroxyl group or a group derived therefrom.

    摘要翻译： 本发明涉及一种用于预防和治疗皮肤疾病的药剂，其包含作为活性成分的作为下式（1）表示的化合物的抗坏血酸衍生物或其盐，本身不具有抗氧化活性， 能够在体内转化成具有抗氧化活性的化合物;其中R1表示能够通过醚或酯键与抗坏血酸骨架的2-位上的碳键合并在体内可转化为羟基的基团 ，R 2〜R 4可以相同或不同，表示羟基或由其衍生的基团。

    L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
    4.
    发明授权
    L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same 失效
    L-抗坏血酸2-磷酸锌盐及其制造方法

    公开(公告)号：US06420419B1

    公开(公告)日：2002-07-16

    申请号：US09095895

    申请日：1998-06-11

    申请人： Masahiro Suzuki ,  Toshi Tsuzuki ,  Shinobu Ito ,  Eiji Ogata

    发明人： Masahiro Suzuki ,  Toshi Tsuzuki ,  Shinobu Ito ,  Eiji Ogata

    IPC分类号： A61K31341

    CPC分类号： A61K31/665 ,  C07D307/62

    摘要： L-Ascorbic acid 2-phosphate zinc salt and a salt hydrate thereof having excellent solubility and exhibiting good stability even under weakly acidic conditions. Also disclosed is a process of manufacturing L-ascorbic acid 2-phosphate zinc salt by displacing a cation of a salt of an L-ascorbic acid 2-phosphate other than a zinc salt with a zinc cation. Further disclosed is a composition containing L-ascorbic acid 2-phosphate zinc salt or a salt hydrate thereof as an active ingredient.

    摘要翻译： L-抗坏血酸2-磷酸锌盐及其盐水合物，即使在弱酸性条件下也具有优异的溶解性和良好的稳定性。 还公开了通过用锌阳离子置换除了锌盐之外的L-抗坏血酸2-磷酸盐的阳离子来制造L-抗坏血酸2-磷酸锌盐的方法。 进一步公开了含有L-抗坏血酸2-磷酸锌盐或其盐水合物作为活性成分的组合物。

    Highly purified tocopheryl phosphate, process for producing the same, analytical method therefor and cosmetic
    5.
    发明授权
    Highly purified tocopheryl phosphate, process for producing the same, analytical method therefor and cosmetic 有权
    高纯度生育磷酸酯，其生产方法，分析方法和化妆品

    公开(公告)号：US6046181A

    公开(公告)日：2000-04-04

    申请号：US342228

    申请日：1999-06-29

    申请人： Yutaka Oonishi ,  Tsutomu Nozawa ,  Takami Ooe ,  Keisuke Mano ,  Naoaki Misu ,  Yohei Kurata ,  Shinobu Ito ,  Eiji Ogata

    发明人： Yutaka Oonishi ,  Tsutomu Nozawa ,  Takami Ooe ,  Keisuke Mano ,  Naoaki Misu ,  Yohei Kurata ,  Shinobu Ito ,  Eiji Ogata

    IPC分类号： A61K8/02 ,  A61K8/67 ,  A61Q1/02 ,  A61Q1/04 ,  A61Q5/02 ,  A61Q7/00 ,  A61Q11/00 ,  A61Q19/00 ,  A61Q19/10 ,  C07F9/655 ,  G01N30/02 ,  G01N30/88 ,  G01N33/82 ,  A61K7/035 ,  A61K7/00 ,  A61K7/02 ,  A61K7/021 ,  A61K7/027

    CPC分类号： G01N33/82 ,  A61K8/0212 ,  A61K8/678 ,  A61Q19/00 ,  C07F9/65522 ,  A61Q1/02 ,  A61Q1/04 ,  A61Q11/00 ,  A61Q19/10 ,  A61Q5/02 ,  A61Q7/00 ,  G01N2030/884 ,  G01N30/02 ,  Y10S514/846

    摘要： Disclosed herein are a highly purified tocopheryl phosphate and/or a salt thereof (tocopheryl phosphates) wherein a P,P'-bistocopheryl hypophosphate and/or a salt thereof (P,P'-bistocopheryl diphoshates) is contained in a proportion of not higher than 3% by weight; a process for producing a highly purified tocopheryl phosphate and/or a salt thereof, which comprises the steps of reacting a tocopherol with an oxyphosphorus trihalide followed by treating with an acid or basic aqueous solution to thereby form tocopheryl phosphates (i) in which P,P'-bistocopheryl diphoshates (ii) formed as by-products are contained, hydrolyzing the P,P'-bistocopheryl diphoshates (ii) under acid condition, and, optionally, rendering the hydrolyzate neutral or basic under basic condition; and a method of analyzing tocopheryl phosphates, comprising analyzing a sample containing components (i) and (ii) with the use of a high-performance liquid chromatograph column packed with a gel of a polymethacrylate having, bonded thereto, long-chain alkyl groups. None or only an extremely minute amount of P,P'-bistocopheryl diphoshates are contained in the highly purified tocopheryl phosphates, so that the highly purified tocopheryl phosphates exhibit antioxidant and blood circulation promoting effects, have excellent water solubility, are powdery so that the handling thereof is extremely easy, are free from cutaneous irritation and allergenecity and ensure dermal safety. Therefore, the highly purified tocopheryl phosphates are useful as cosmetic ingredients. The amounts of components (i) and (ii) can be simply measured with high accuracy by the above method.

    摘要翻译： 本文公开了高纯度的生育磷酸酯和/或其盐（生育磷酸酯），其中P，P'-二生育酚低磷酸盐和/或其盐（P，P'-二生育基二磷酸酯）的含量不高于 超过3％重量; 一种生产高纯度生育磷酸酯和/或其盐的方法，其包括使生育酚与三卤氧磷反应，然后用酸或碱性水溶液处理，从而形成生育磷酸酯（i），其中P， 含有作为副产物形成的P'-二生育基二磷酸酯（ⅱ），在酸性条件下水解P，P'-二生育基二磷酸酯（ⅱ），任选地在碱性条件下使水解产物中性或碱性。 以及分析生育磷酸酯的方法，包括使用填充有与其键合的聚甲基丙烯酸酯的凝胶的高效液相色谱柱分析含有成分（i）和（ii）的样品的长链烷基。 高纯度的生育磷酸酯中没有或仅有非常少量的P，P'-二生育基二磷酸酯，因此高纯度的生育磷酸酯表现出抗氧化和促进血液循环的作用，具有优异的水溶性，是粉末状的， 它非常容易，没有皮肤刺激和过敏原，并确保皮肤安全。 因此，高纯度的生育磷酸酯可用作化妆品成分。 组分（i）和（ii）的量可以通过上述方法以高精度简单地测量。

    Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
    6.
    发明授权
    Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals 失效
    向动物施用维生素E的方法以及含有生育磷酸酯及其盐的动物的组合物

    公开(公告)号：US6022867A

    公开(公告)日：2000-02-08

    申请号：US980371

    申请日：1997-11-28

    申请人： Shinobu Ito ,  Eiji Ogata

    发明人： Shinobu Ito ,  Eiji Ogata

    IPC分类号： A23K1/16 ,  A23L1/32 ,  A61K31/665 ,  G01N33/82 ,  A61K31/355

    CPC分类号： A61K31/665 ,  A23K20/174 ,  A23L15/00 ,  G01N33/82

    摘要： A vitamin E source composition for administration to animals, which comprises a tocopheryl phosphate, a salt thereof or a composition containing a tocopheryl phosphate or a salt thereof. Also, disclosed is a method of supplying vitamin E to animals which comprises administering to animals the above vitamin E source composition. The tocopheryl phosphoric acid and a salt thereof can be formed into a composition and also can contain an antioxidant or the like.

    摘要翻译： 一种用于给予动物的维生素E源组合物，其包含生育磷酸酯，其盐或含有生育磷酸酯或其盐的组合物。 此外，还公开了向动物提供维生素E的方法，其包括向动物施用上述维生素E源组合物。 生育磷酸及其盐可以形成为组合物，也可以含有抗氧化剂等。

    Ascorbic acid derivative and vitamin C preparation containing the same
    7.
    发明授权
    Ascorbic acid derivative and vitamin C preparation containing the same 失效
    抗坏血酸衍生物和含有相同的维生素C制剂

    公开(公告)号：US6127409A

    公开(公告)日：2000-10-03

    申请号：US70012

    申请日：1998-04-30

    申请人： Masahiro Suzuki ,  Toshi Tsuzuki ,  Shinobu Ito ,  Eiji Ogata

    发明人： Masahiro Suzuki ,  Toshi Tsuzuki ,  Shinobu Ito ,  Eiji Ogata

    IPC分类号： A61K8/67 ,  A61Q19/00 ,  C07F9/655 ,  A01N43/08 ,  C07D307/02

    CPC分类号： C07F9/65515 ,  A61K8/676 ,  A61Q19/00 ,  A61K2800/52

    摘要： A novel ascorbic acid derivative having both sufficiently improved stability and liposolubility, and facilitated cellular uptake. Also disclosed is a process for producing the derivative and a composition capable of effectively providing the action of vitamin C, for use in medical preparations, agricultural chemicals, animal drugs, foods, feeds or cosmetic preparations. The ascorbic acid derivative is a compound represented by the following formula (1) or a salt thereof: ##STR1## wherein R represents an acyl group having eleven or more carbon atoms and n is 0, 1 or 2.

    摘要翻译： 具有足够改善的稳定性和脂溶性的新型抗坏血酸衍生物，促进细胞摄取。 还公开了一种生产该衍生物的方法和能够有效提供维生素C作用的组合物，用于医疗制剂，农药，动物药物，食品，饲料或化妆品制剂。 抗坏血酸衍生物是由下式（1）表示的化合物或其盐：其中R表示具有11个或更多个碳原子且n为0,1或2的酰基。

    Ascorbic acid drugs for intracerebral administration
    8.
    发明授权
    Ascorbic acid drugs for intracerebral administration 失效
    抗坏血酸药物用于脑内给药

    公开(公告)号：US5869525A

    公开(公告)日：1999-02-09

    申请号：US647767

    申请日：1996-05-15

    申请人： Shinobu Ito ,  Eiji Ogata ,  Nobuhiko Miwa

    发明人： Shinobu Ito ,  Eiji Ogata ,  Nobuhiko Miwa

    IPC分类号： A61K31/375 ,  A61K31/34 ,  A61K31/70 ,  A61K31/715

    CPC分类号： A61K31/375

    摘要： An L-ascorbic acid drug for intracerebral administration comprising one or more stable activity L-ascorbic acid compounds and one or more blood brainbarrier deobstruents. Also disclosed is a method for increasing intracerebral concentration of L-ascorbic acid in a human being comprising administering by injection an L-ascorbic acid drug comprising one or more stable activity L-ascorbic acid compounds. Additionally disclosed is a method for increasing intracerebral concentration of L-ascorbic acid in a human being comprising administering by injection an L-ascorbic acid drug comprising one or more stable activity L-ascorbic acid compounds and one or more blood brainbarrier deobstruents. Also disclosed is a method for treating diseases or disorders that result from intracerebral bloodstream inhibition or intracerebral bloodstream lowering comprising administering by injection to a person in need of such treatment, a dosage effective amount of an L-ascorbic acid drug comprising one or more stable activity L-ascorbic acid compounds. Additionally disclosed is a method for treating diseases or disorders that result from intracerebral bloodstream inhibition or intracerebral bloodstream lowering comprising administering by injection to a person in need of such treatment, a dosage effective amount of an L-ascorbic acid drug comprising one or more stable activity L-ascorbic acid compounds and one or more blood brainbarrier deobstruents.

    摘要翻译： 一种用于脑内给药的L-抗坏血酸药物，其包含一种或多种稳定的活性L-抗坏血酸化合物和一种或多种血液脑阻滞剂。 还公开了增加人体中L-抗坏血酸的脑内浓度的方法，包括通过注射施用包含一种或多种稳定活性L-抗坏血酸化合物的L-抗坏血酸药物。 另外公开了一种增加人抗坏血酸的脑内浓度的方法，包括通过注射施用包含一种或多种稳定的活性L-抗坏血酸化合物和一种或多种血脑屏障去除剂的L-抗坏血酸药物。 还公开了一种用于治疗由脑内血流抑制或脑内血流降低引起的疾病或病症的方法，其包括通过注射给予需要这种治疗的人，剂量有效量的包含一种或多种稳定活性的L-抗坏血酸药物 L-抗坏血酸化合物。 另外公开了一种治疗由脑内血流抑制或脑内血流降低引起的疾病或病症的方法，其包括通过注射给予需要这种治疗的人，剂量有效量的包含一种或多种稳定活性的L-抗坏血酸药物 L-抗坏血酸化合物和一种或多种血脑屏障阻断剂。